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Objectives. To explore the differences between primary and redo urethroplasty and to directly compare according stricture-free
survival (SFS).Materials and Methods. Data of all male patients who underwent urethroplasty at Ghent University Hospital were
collected between 2000 and 2018. Exclusion criteria for this analysis were age <18 years and follow-up <1 year. Two patient groups
were created for further comparison: the primary urethroplasty (PU) group (no previous urethroplasty) and redo urethroplasty
(RU) group (≥1 previous urethroplasty), irrespective of prior endoscopic treatments. A comparison between groups was per-
formed using the Mann–Whitney U test and Fisher’s Exact test. SFS was calculated using Kaplan–Meier statistics. A functional
definition of failure, being the need for further urethral manipulation, was used. Uni- and multivariate Cox regression analyses
were performed on the entire patient cohort. Results. 805 patients were included. Median (IQR) follow-up of the PU (n� 556) and
RU (n� 249) groups was 87 (50–136) and 76 (40–133) months, respectively (p � 0.1). *e RU group involved more penile
strictures (p< 0.001), Lichen Sclerosus (p � 0.016), failed hypospadias repair (p � 0.004), multistage procedures (p< 0.001), and
definitive perineostomies (p � 0.001). *e 5- and estimated 10-year SFS was, respectively, 86% and 79% for the PU group and,
respectively, 75% and 63% for the RU group (p< 0.001). Prior urethroplasty (HR: 1.52; p � 0.01) and diabetes (HR: 1.83; p � 0.03)
remained statistically significant in the multivariate Cox regression analysis. Conclusions. Several differences between primary and
redo urethroplasties exist. Redo urethroplasty entails a distinct patient population to treat and is, in general, associated with lower
stricture-free survival than primary urethroplasty, although more homogeneous series are required to corroborate these results.
Prior urethroplasty and diabetes are independent risk factors for urethroplasty failure.
1. Introduction
Urethroplasty is considered the standard treatment option
for urethral stricture disease (USD) as it offers substantially
higher long-term success rates than direct vision internal
urethrotomy (DVIU) or urethral dilatation [1, 2]. However,
despite its satisfying outcome, there is a subgroup of patients
in which failure is encountered. Several risk factors for
failure after urethroplasty have been described, among
which prior therapy for USD [3–6]. Against this back-
ground, the question whether redo urethroplasty provides
the same satisfying outcome as primary urethroplasty should
be considered.
So far, scarce data are available on the management of
recurrent USD and only little is known about the differences
between primary and redo urethroplasty. A redo ure-
throplasty is often more challenging as recurrent urethral
strictures usually have denser and more extensive scar tissue.
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Moreover, since potential grafts or flaps may have already
been used in previous urethroplasties, the armamentarium
of the surgeon becomes smaller in a redo setting [7].
Be that as it may, the prognostic significance of prior
urethroplasty remains highly controversial since several
authors have published their experience with redo ure-
throplasty and reported success rates equivalent to primary
urethroplasty [5, 7–14]. However, these reports contain
several limitations and the different definitions of failure and
different follow-up protocols make it hard to draw adequate
conclusions [15]. To date, the largest comparative series was
published by Levine et al., but included only 49 redo pro-
cedures and despite the differences in stricture length,
stricture location, and applied surgical technique between
groups, a Cox regression analysis to confirm the prognostic
value of these characteristics was not performed [11]. Un-
doubtedly, additional evidence upon this subject is required
and should be based on a comparative analysis with a higher
volume of redo urethroplasties.
Considering the above, the aim of this study is to explore
the differences between primary and redo urethroplasty and
to directly compare the according stricture-free survival
(SFS), with more power than the existing reports.
2. Patients and Methods
2.1. Patients. A database of all male patients who underwent
urethroplasty at Ghent University Hospital was enrolled
between 2000 and 2018. *is database contains extensive
information about patient and stricture characteristics,
previous interventions, and other relevant information
(suprapubic catheter, urinary tract infection (UTI)). Ex-
clusion criteria for this analysis were age <18 years and
duration of follow-up <1 year. Within the included patients,
two patient groups were created for further comparison: the
primary urethroplasty (PU) group, defined as patients
without previous urethroplasty, and the redo urethroplasty
(RU) group, defined as patients who underwent ≥1 ure-
throplasty, both irrespective of prior DVIU/dilatation. *e
study was approved by the local Ethics Committee (EC/
2014/0438) and all included patients provided written in-
formed consent.
2.2. Perioperative Management. Preoperatively, patients
were evaluated through history taking, physical examina-
tion, and technical investigations (uroflowmetry, ultrasonic
residue measurement and retrograde urethrography (RUG)
and/or voiding cystourethrography (VCUG) and/or cys-
toscopy). A urine culture was performed one week before
urethroplasty and appropriate antibiotics were started 24
hours before surgery in case of infection. All operations were
performed by two surgeons (W. O. and N. L.).
Generally, a VCUG was performed fourteen days
postoperatively and in case of no extravasation of contrast,
the transurethral catheter was removed. In cases with
contrast extravasation, the transurethral catheter was
replaced and a VCUG was again performed one week later.
Follow-up visits included history taking, physical ex-
amination, and uroflowmetry and were performed after
three months, after one year, and annually thereafter. Ad-
ditional technical investigations were only administered in
case of arguments for urethroplasty failure such as symp-
toms or an obstructive voiding curve (<15ml/s). A subgroup
of patients was followed by the referring urologist due to
practical considerations.
2.3. Statistical Analysis. Baseline and per- and postoperative
characteristics were analyzed using descriptive statistics. *e
comparison between groups was performed using the
Mann–WhitneyU test and Fisher’s Exact test for continuous
and categorical variables, respectively. Complications within
90 days postoperatively were categorized according to the
Clavien–Dindo classification system [16]. For SFS, the time-
to-event was measured as the interval between the operation
date and the date of the diagnosis of the failure. A functional
definition of failure, being the need for further urethral
manipulation (including simple dilatation), was used [17].
Patients were censored at the time of the latest follow-up or
death. SFS was calculated using Kaplan–Meier statistics and
groups were compared using the Log-Rank test. Uni- and
multivariate Cox regression analyses with the calculation of
the Hazard Ratio (HR) to predict failure were performed on
the entire patient cohort for the following variables: age,
stricture length, location, etiology, previous interventions,
urethroplasty technique, comorbidities, presence of supra-
pubic catheter, and UTI. Only the statistically significant
variables from the univariate analysis were entered in the
multivariate analysis. All statistical tests were 2-sided and a p
value <0.05 was considered statistically significant. *e
analysis was performed using SPSS® 25.0.
3. Results
In total, 805 patients were included in this study.*emedian
follow-up of the PU group (n� 556) and RU group (n� 249)
was 87 and 76 months, respectively (p � 0.1). Baseline
characteristics are displayed in Table 1. Age, follow-up,
stricture length, and comorbidities were comparable be-
tween groups. Penile strictures (p< 0.001), strictures due to
Lichen Sclerosus (p � 0.016), and strictures due to failed
hypospadias repair (p � 0.004) were significantly more
frequent in the RU group. RU techniques comprised sig-
nificantly more multistage procedures (p< 0.001) and de-
finitive perineal urethrostomies (p � 0.001) and significantly
less anastomotic repairs (p< 0.001) and free graft ure-
throplasties (p � 0.028). In both groups, “other ure-
throplasty techniques” mainly consisted of meatoplasties
(>95%), which were proportionally more frequently per-
formed in the RU group (p � 0.004).
Per- and postoperative characteristics are displayed in
Table 2. *e hospital stay was significantly longer in the PU
group (p � 0.01), in contrast to the comparable operation
time, catheter stay and extravasation ratio. *e compli-
cation rate was 25% and 24% for the PU and RU groups,
respectively. In both groups, complications were pre-
dominantly low-grade (Clavien–Dindo grade 1-2: 175/805;
22%) [16]. Grade 3 complications involved urinary
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retention with placement of a suprapubic catheter (3/805;
0.37%) and hematomas (5/805; 0.62%), abscesses (5/805;
0.62%), fistulas (13/805; 1.6%), and Fournier gangrene (1/
805; 0.12%) requiring surgical intervention.
In the PU and RU groups, respectively, 95 (17%) and 68
(27%) patients suffered a failure. *e 5- and estimated 10-
year SFS were, respectively, 86% (95% CI: 83–89%) and 79%
(95% CI: 75–83%) for the PU group and, respectively, 75%
(95% CI: 69–81%) and 63% (95% CI: 55–71%) for the RU
group (p< 0.001) (Figure 1, Table 2). Respectively, 38 (40%),
33 (35%), and 24 (25%) failures from the PU group and 29
(43%), 25 (36%), and 14 (21%) failures from the RU group
occurred within the first postoperative year, between the first
and fifth postoperative years and after more than five years
postoperatively.
Univariate analysis identified longer strictures (HR: 1.05;
p � 0.003), multifocal strictures (HR: 2.30; p< 0.001), iat-
rogenic strictures (HR: 1.37; p � 0.044), failed hypospadias
repair (HR: 2.02; p � 0.001), prior urethroplasty (HR: 1.78;
p< 0.001), and diabetes (HR: 1.83; p � 0.04) as risk factors
for failure (Table 3). Prior urethroplasty (HR: 1.52; p � 0.01)
and diabetes (HR: 1.83; p � 0.03) were identified as
Table 1: Baseline characteristics.
Total (n� 805) PU (n� 556) RU (n� 249) p value
Median age (years) (IQR) 51 (36–63) 53 (36–65) 50 (36–62) 0.3
Median follow-up (months) (IQR) 83 (46–135) 87 (50–136) 76 (40–133) 0.1
Median stricture length (cm) (IQR) 3.0 (1.5–6.0) 3.0 (1.5–6.3) 3.0 (2.0–6.0) 0.5
Stricture location n (%)
Penile 207 (26) 121 (22) 86 (35) <0.001
Bulbar 365 (45) 271 (49) 94 (38) 0.005
Posterior 102 (13) 84 (15) 18 (7.2) 0.002
Multifocal 63 (7.8) 41 (7.4) 22 (8.8) 0.5
Panurethral 59 (7.3) 39 (7.0) 20 (8.0) 0.7
Meatus of perineostomy 9 (1.1) 0 (0) 9 (3.6) <0.001
Stricture etiology n (%)
Idiopathic 276 (34) 178 (32) 98 (39) 0.050
Iatrogenic 336 (42) 247 (44) 89 (36) 0.025
External trauma 111 (14) 83 (15) 28 (11) 0.2
Inflammatory 73 (9.1) 41 (7.4) 32 (13) 0.016
Failed hypospadias repair 75 (9.3) 40 (7.2) 35 (14) 0.004
Tumor 9 (1.1) 7 (1.3) 2 (0.80) 0.7
Previous interventions n (%)
None 170 (21) 170 (31) 0 (0) <0.001
1 DVIU/dilatation 125 (16) 125 (23) 0 (0) <0.001
>1 DVIU/dilatation 259 (32) 258 (46) 1 (0.40) <0.001
Urethroplasty 88 (11) 0 (0) 88 (35) <0.001
Urethroplasty +DVIU/dilatation 159 (20) 0 (0) 159 (64) <0.001
Endoscopic realignment 3 (0.37) 2 (0.36) 1 (0.40) >0.9
Open realignment 1 (0.12) 1 (0.18) 0 (0) >0.9
Urethroplasty technique n (%)
Transecting anastomotic repair 206 (26) 162 (29) 44 (18) <0.001
Nontransecting anastomotic repair 115 (14) 91 (16) 24 (9.6) <0.001
Free graft urethroplasty 264 (33) 196 (35) 68 (27) 0.028
Pedicled flap urethroplasty 42 (5.2) 26 (4.7) 16 (6.4) 0.3
Combined 35 (4.3) 19 (3.4) 16 (6.4) 0.1
Multistage urethroplasty 38 (4.7) 13 (2.3) 25 (10) <0.001
Definitive perineostomy 43 (5.3) 17 (3.1) 26 (10) <0.001
Others 62 (7.7) 32 (5.8) 30 (12) 0.004
Comorbidity n (%)
Smoking 110 (14) 77 (15) 33 (14) 0.8
Diabetes 55 (7.1) 34 (6.4) 21 (8.7) 0.3
Cardiovascular comorbidity 138 (18) 97 (18) 41 (17) 0.7
Suprapubic catheter n (%) 192 (24) 147 (26) 45 (18) 0.01
UTI n (%) 216 (27) 157 (28) 59 (24) 0.2
PU� primary urethroplasty; RU� redo urethroplasty; IQR� interquartile range; cm� centimeters; DVIU� direct vision internal urethrotomy; UTI� urinary
tract infection. p values comparing the PU group and RU group <0.05 are highlighted in bold.
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independent risk factors for failure in the multivariate
analysis (Table 3).
4. Discussion
*e aim of this study was to distinguish the primary and
redo urethroplasty group and to compare the according SFS.
Current literature shows similar success rates for primary
and redo urethroplasty [7–14], although a majority of these
papers indirectly compared the results of redo urethroplasty
with success rates of primary procedures [8] or did not
compare the results at all [7, 9, 12–14]. Since patient and
stricture characteristics, definitions of failure and follow-up
protocols vary among different patient series, indirect
comparison is hazardous and insufficient to draw adequate
conclusions. Two authors published a direct comparison
between primary and redo urethroplasty, but these retro-
spective studies are underpowered in the amount of in-
cluded redo procedures (37 and 49 respectively) [10, 11].
Hypothetically, considering 10% difference in SFS to be
clinically relevant, a trial with a two-sided alpha of 0.05 and
80% power would require 248 patients per group to establish
clinically relevant superiority for primary urethroplasty
(assuming a SFS rate of 85% and 75% for the PU and RU
group, respectively). To the best of our knowledge, this study
is the first direct comparison between primary and redo
urethroplasty with this amount of redo procedures and in
our opinion, the results are noteworthy put the success rate
of redo urethroplasty in perspective and contribute to more
realistic patient expectations.
Several differences in baseline characteristics between
the PU and RU groups existed. Penile strictures were sig-
nificantly more frequent in the RU group, which could be
explained by the fact that penile strictures are in most cases
ineligible for anastomotic repair (AR) urethroplasty, which
offers the highest success rate [18]. Usually, these strictures
require a substitution urethroplasty and, as the success rate
of these procedures deteriorates over time, the likelihood of
being treated with a redo urethroplasty increases along
[15, 18, 19]. Additionally, Lichen Sclerosus and failed hy-
pospadias repair are associated with a higher failure rate and
predominantly affect the penile urethra [7, 20, 21]. *is in
turn also explains why these etiologies were significantly
more frequent in the RU group.
*e redo stricture profile, as outlined above, warrants
adapted operative strategies which are reflected in the ap-
plied surgical techniques [7, 20, 22]. Significantly fewer
strictures were eligible for AR urethroplasty, whereas
multistage procedures and definitive perineostomies were
significantly more performed. *is result is in line with the
observations of Levine et al. [11]. Also, free graft ure-
throplasty was performed less frequently in the RU group.
*is may be explained by the fact that prior urethral surgery
can impair the urethral blood supply and thus lead to a
poorly vascularized, unsuitable graft bed for future urethral
reconstructions. As regards the discrepancies in hospital stay
Table 2: Pre- and postoperative characteristics.
Total (n� 805) PU (n� 556) RU (n� 249) p value
Median operation time (min) (IQR) 105 (82–131) 105 (83–130) 105 (80–135) 0.8
Median hospital stay (days) (IQR) 3 (2–4) 3 (2–4) 2 (2–4) 0.01
Median catheter stay (days) (IQR) 14 (10–15) 14 (11–15) 14 (9–15) 0.5
Significant extravasation at first VCUG n (%) 44 (7.7) 31 (7.2) 13 (8.8) 0.6
Complications (Clavien–Dindo) n (%)
None 606 (75) 417 (75) 189 (76) 0.9
Grade 1 114 (14) 82 (15) 32 (13) 0.5
Grade 2 61 (7.6) 39 (7.0) 22 (8.8) 0.4
Grade 3 24 (3.0) 18 (3.2) 6 (2.4) 0.7
Stricture-free survival estimates % (SD)
1 y-SFS 94 (1.0) 88 (2.1)
<0.0012 y-SFS 91 (1.2) 83 (2.4)5 y-SFS 86 (1.5) 75 (3.0)
10 y-SFS 79 (2.1) 63 (4.2)
PU� primary urethroplasty; RU� redo urethroplasty; min�minutes; IQR� interquartile range; VCUG� voiding cystourethrography; SD� standard de-
viation; SFS� stricture-free survival. p values comparing the PU group and RU group <0.05 are highlighted in bold.
0PU 556 454 359  260 205 145 86 45 11
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Figure 1: Kaplan–Meier curve for stricture-free survival in primary
and redo urethroplasty. PU� primary urethroplasty; RU� redo
urethroplasty; no.� numbers.
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between groups, patients often experience some degree of
discomfort after harvesting an oral graft and this may
contribute to the longer hospital stay, as observed in the PU
group [23]. Meanwhile, staged procedures and perineos-
tomies allow a relatively short hospital stay and even day
surgery.
As regards surgical outcome, SFS was significantly lower
in the RU group compared to the PU group, which distinctly
contradicts prior literature suggesting that primary and redo
urethroplasties have an equivalent outcome in terms of SFS
[7–14]. However, our findings actually do corroborate the
results from Blaschko et al., who described the largest redo
urethroplasty series so far [7]. *ey reported a “primary
success rate” of 67% after a median follow-up of 55 months,
which is in line with our results as their definition of
“primary success” corresponds with our definition of suc-
cess. However, since an additional 12% of their patients
remained stricture-free after the first salvage treatment, a
total success rate of 78% was reported [7]. Rosenbaum et al.
specifically focused on redo buccal mucosa graft ure-
throplasty and reported a success rate of 82% [8], albeit after
a median follow-up of only 16 months, while it is established
that the results of substitution urethroplasty strongly
deteriorate over time [8, 19]. Siegel et al. directly compared
primary and redo AR urethroplasties and described com-
parable results between both groups [10]. However, their
sample of 37 redo procedures only contained patients with
recurrent urethral strictures eligible for AR urethroplasty,
representing only a favorable minority of the total patient
population presenting with recurrent USD [10].*e fact that
our dataset contains a mix of various techniques with dif-
ferent patient and stricture characteristics might explain
these conflicting results. As for Levine et al., who reported
the largest comparative series so far, redo urethroplasty
succeeded in 92% of the cases, which was comparable with
primary urethroplasty [11]. *eir patient series, however,
contained only 49 redo procedures and, despite the different
stricture length, stricture location, and applied surgical
techniques of their RU group, no Cox regression analyses
were performed. Furthermore, our RU group contained
substantially more penile, multifocal, panurethral, Lichen
Sclerosus, and failed hypospadias repair cases which are all
associated with increased stricture complexity [20–22].
Additionally, the higher success rate of Levine et al. could be
explained by the fact that more than 20% of the failures of
our RU group occurred after more than five years of follow-
Table 3: Uni- and multivariate Cox regression analysis.
Univariate Multivariate
HR (95% CI) p value HR (95% CI) p value
Age 1.00 (0.99–1.01) 0.7
Stricture length 1.05 (1.02–1.08) 0.003 1.00 (0.95–1.06) >0.9
Stricture location
Penile 1.38 (0.99–1.92) 0.1
Bulbar 0.51 (0.36–0.71) <0.001 0.65 (0.42–1.01) 0.055
Posterior 0.76 (0.46–1.28) 0.3
Multifocal 2.30 (1.47–3.58) <0.001 1.71 (0.98–3.00) 0.059
Panurethral 1.45 (0.90–2.35) 0.1
Stricture etiology
Idiopathic 0.79 (0.56–1.11) 0.2
Iatrogenic 1.37 (1.01–1.86) 0.044 1.11 (0.77–1.60) 0.6
External trauma 0.65 (0.39–1.09) 0.1
Inflammatory 1.36 (0.85–2.18) 0.2
Failed hypospadias repair 2.02 (1.32–4.10) 0.001 1.27 (0.70–2.29) 0.4
Previous interventions
≥1 prior DVIU/dilatation 0.79 (0.58–1.07) 0.1
≥1 prior urethroplasty 1.78 (1.30–2.43) <0.001 1.52 (1.08–2.14) 0.01
Urethroplasty technique
Anastomotic repair 0.46 (0.32–0.66) <0.001 0.61 (0.36–1.03) 0.1
Free graft urethroplasty 1.23 (0.89–1.68) 0.2
Pedicled flap urethroplasty 1.53 (0.88–2.66) 0.1
Multistage urethroplasty 0.66 (0.27–1.61) 0.4
Definitive perineostomy 1.20 (0.63–2.28) 0.6
Comorbidity
Smoking 1.02 (0.65–1.62) 0.9
Diabetes 1.83 (1.09–3.08) 0.04 1.83 (1.07–3.11) 0.03
Cardiovascular comorbidity 1.22 (0.81–1.86) 0.3
Suprapubic catheter 0.67 (0.45–1.00) 0.050
UTI 0.91 (0.64–1.31) 0.6
HR� hazard ratio; CI� confidence interval; DVIU� direct vision internal urethrotomy; UTI� urinary tract infection. p values comparing the PU group and
RU group <0.05 are highlighted in bold.
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up. *ese failures may have been missed in their study as
their mean follow-up was only 50 months [11]. Other re-
searchers have investigated the redo urethroplasty setting as
well, but their reports are characterized by a restricted
sample size or a limited follow-up [9, 12–14]. Our patient
series demonstrates that urethroplasty demands a prolonged
follow-up since a significant amount of failures was observed
after more than five years postoperatively, which is in line
with the report from Han et al. [6]. An anatomical definition
of failure (impossible passage of the cystoscope through the
reconstructed area) could possibly detect more and earlier
failures [17]. However, to date, no consensus about the
definition of failure exists among urologic societies or expert
panels [15].
Given the several differences in baseline characteristics
between both groups, a Cox regression analysis was per-
formed to investigate their prognostic value in the present
dataset. However, in the multivariate analysis, only two
characteristics remained statistically significant: prior ure-
throplasty and diabetes. *is result underlines the observed
differences in SFS between the PU and RU groups and
confirms that, in this dataset, prior urethroplasty is pre-
dictive for urethroplasty failure, which corresponds with
previous reports [5–7]. As for diabetes, it is known that the
inherent microangiopathy contributes to a poorer vascu-
larization, also at the urethral site, potentially impeding the
healing of the urethra after surgery. *is in turn can lead to
an increased risk for failure [5]. Apart from these, other
predictive factors for urethroplasty failure have been put
forward as well, although significant differences in the in-
vestigated patient cohorts exist and might explain the in-
consistent nature of these findings [3–6].
*is study has various limitations. Before 2008, data
were collected retrospectively and, since this cohort spans
seventeen years, surgical techniques and perioperative
management may have changed over time. Furthermore,
every patient was offered a follow-up regimen at our in-
stitution, but a subset of patients was followed by the re-
ferring urologist, involving a risk of underreporting failures
and potentially explaining a delayed detection of failures. No
systematic endoscopic evaluation of urethral patency was
performed and thus asymptomatic stricture formation after
urethroplasty was not recorded. Also, this patient cohort
represents a highly heterogeneous group involving several
differences in baseline characteristics between the compared
groups.*e aim of this study was to explore these differences
and to compare the according SFS in a patient cohort which
is reflective for a tertiary reconstructive center with a
minimum of exclusion criteria. Be that as it may, the
aforementioned differences in SFS should be interpreted
carefully, given the heterogenic nature of our comparison.
However, none of the baseline characteristics, except for
prior urethroplasty and diabetes, were found to be an in-
dependent risk factor for failure in the present dataset.
Future studies ideally involving prospective multicenter data
collection with a uniform follow-up protocol and definition
of failure are required to corroborate these results in specific,
more homogeneous patient subgroups and to enrich the
evidence on managing recurrent USD.
5. Conclusions
In conclusion, several differences between primary and redo
urethroplasties exist. Redo urethroplasty entails a distinct
patient population to treat and is, in general, associated with
lower stricture-free survival than primary urethroplasty,
although more homogeneous series are required to cor-
roborate these results. Prior urethroplasty and diabetes are















USD: Urethral stricture disease
UTI: Urinary tract infection
VCUG: Voiding cystourethrography.
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